Pacific Shuanglin Bio-pharmacy Co., LTD

SZSE:000403.SZ

21.78 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

20232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001200019991998199719961995
Revenue 2,328.7232,405.1881,971.7341,049.938915.657859.843685.378567.436500.269489.496477.716469.824461.068545.673465.911578.801645.031674.9742.951669.811651.812467.956422.25381.184349.952191.571157.446143.333141.891
Cost of Revenue 1,129.8781,151.4431,063.309537.358436.412401.328294.841249.566235.434210.045190.68178.753152.062242.247248.672416.16481.672558.549605.234535.22501.311326.372256.877211.35211.792125.757111.776105.124105.923
Gross Profit 1,198.8451,253.745908.425512.58479.244458.516390.537317.871264.835279.451287.035291.072309.007303.426217.238162.641163.359116.351137.717134.591150.501141.584165.373169.834138.1665.81445.6738.2135.968
Gross Profit Ratio 0.5150.5210.4610.4880.5230.5330.570.560.5290.5710.6010.620.670.5560.4660.2810.2530.1720.1850.2010.2310.3030.3920.4460.3950.3440.290.2670.253
Reseach & Development Expenses 79.68575.36535.6310.99614.73228.58829.3926.76924.12819.08526.88116.31428.45928.379000000000000000
General & Administrative Expenses 50.8139.16543.89827.22722.55351.00774.28752.84242.16926.80835.66335.50426.27752.066121.23782.46974.6375.892530.753275.01961.34555.15650.07730.86237.44714.35812.90112.59412.777
Selling & Marketing Expenses 285.567399.569229.27158.624144.642146.4278.15149.54511.1256.69817.67216.20421.0522.31621.71827.42331.67240.10647.28132.33618.32915.94511.29810.40811.2256.5667.3364.1923.562
SG&A 336.377438.733273.168185.851167.195197.427152.438102.38753.29333.50653.33551.70847.32774.382142.956109.893106.302115.998578.034307.35579.67471.161.37541.27148.67220.92420.23716.78616.338
Other Expenses -1,633.584128.245150.03592.83290.842107.9587.36413.6455.04547.597113.186-25.749-20.19123.597-0.713200.024117.05414.862-82.86814.3814.00310.55120.23323.7825.8330.3393.6897.943-1.534
Operating Expenses 1,633.584642.344458.833289.678272.77333.965269.192227.852158.393134.118152.919136.429143.373163.518145.029111.867107.644117.726580.884308.98880.59472.36462.32642.17450.14122.14521.24917.5217.355
Operating Income 695.14663.429460.427220.296180.038130.98683.63655.15468.318100.25158.86653.13253.218-8.923-20.381-0.037-31.539-103.419-540-225.93935.02743.28983.711122.71887.61134.40221.32919.92612.838
Operating Income Ratio 0.2990.2760.2340.210.1970.1520.1220.0970.1370.2050.1230.1130.115-0.016-0.044-0-0.049-0.153-0.727-0.3370.0540.0930.1980.3220.250.180.1350.1390.09
Total Other Income Expenses Net -7.031-3.037-2.416-3.1038.967-33.397-39.212-21.24-14.1832.508-45.477-127.283-132.606-125.633-93.491149.21329.8-96.32-175.261-61.824-35.71-22.816-2.64815.627-4.753-8.942-0.678-9.077-4.914
Income Before Tax 688.109660.392458.011217.193189.00597.58944.42568.77992.259147.84188.63927.3633.02714.275-21.282199.98685.515-93.125-620.64-223.8936.61350.122102.172144.89298.35534.73424.38119.7412.502
Income Before Tax Ratio 0.2950.2750.2320.2070.2060.1130.0650.1210.1840.3020.1860.0580.0720.026-0.0460.3460.133-0.138-0.835-0.3340.0560.1070.2420.380.2810.1810.1550.1380.088
Income Tax Expense 75.99872.70266.47134.50931.16722.64929.1824.45825.41940.90924.63424.82529.07925.18418.71914.15310.5828.1261.2253.2646.5112.7840.351.1893.2887.2933.7053.1394.146
Net Income 612.111587.131391.064185.965160.44879.98315.24553.89677.563122.51770.2832.57440.70629.2272.328202.00834.608-76.398-521.479-193.17724.00444.91778.91119.07280.17423.79520.67616.6028.356
Net Income Ratio 0.2630.2440.1980.1770.1750.0930.0220.0950.1550.250.1470.0690.0880.0540.0050.3490.054-0.113-0.702-0.2880.0370.0960.1870.3120.2290.1240.1310.1160.059
EPS 0.840.80.550.380.330.150.0290.0940.140.230.130.0620.0970.0720.0050.490.082-0.18-1.23-0.460.0580.110.210.280.310.0980.0940.130.02
EPS Diluted 0.840.80.550.380.330.150.0290.0940.140.230.130.0620.0970.0720.0050.490.082-0.18-1.23-0.460.0580.110.210.280.310.0980.0940.130.02
EBITDA 695.14805.128622.398285.406269.352180.015131.02156.223178.22269.762206.983159.411179.202183.332124.925304.553235.96274.774-460.831-119.454103.815103.159144.87140.5396.42950.38124.42220.68918.613
EBITDA Ratio 0.2990.3350.3160.2720.2940.2090.1910.2750.3560.5510.4330.3390.3890.3360.2680.5260.3660.111-0.62-0.1780.1590.220.3430.3690.2760.2630.1550.1440.131